Walgreens Boots Alliance Inc (WBA) Shares Bought by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA raised its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 161,793 shares of the pharmacy operator’s stock after buying an additional 3,681 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Walgreens Boots Alliance were worth $12,494,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Hudock Capital Group LLC grew its stake in shares of Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the last quarter. Modera Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.4% in the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after purchasing an additional 9 shares during the last quarter. Flagship Harbor Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock worth $243,000 after purchasing an additional 16 shares during the last quarter. Sowell Financial Services LLC grew its stake in shares of Walgreens Boots Alliance by 0.6% in the 1st quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock worth $218,000 after purchasing an additional 17 shares during the last quarter. Finally, WealthTrust Arizona LLC grew its stake in shares of Walgreens Boots Alliance by 0.4% in the 2nd quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock worth $412,000 after purchasing an additional 21 shares during the last quarter. 61.41% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $70.36 on Friday. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The company has a market cap of $71,315.52, a P/E ratio of 14.12, a P/E/G ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period last year, the company posted $1.07 earnings per share. analysts anticipate that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

Walgreens Boots Alliance announced that its board has initiated a share buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.

Several research analysts have commented on WBA shares. Pivotal Research decreased their target price on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, October 24th. Loop Capital started coverage on shares of Walgreens Boots Alliance in a report on Thursday, August 24th. They issued a “buy” rating and a $95.00 target price for the company. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. Deutsche Bank started coverage on shares of Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Finally, BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus price target of $86.47.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://ledgergazette.com/2017/12/15/walgreens-boots-alliance-inc-wba-shares-bought-by-loring-wolcott-coolidge-fiduciary-advisors-llp-ma.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply